The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2005
Filed:
Aug. 08, 2003
Edgardo Laborde, Foster City, CA (US);
Louise Robinson, San Carlos, CA (US);
Fanying Meng, San Francisco, CA (US);
Brian T. Peterson, Mountain View, CA (US);
Hugo O. Villar, La Jolla, CA (US);
Steven E. Anuskiewicz, San Bruno, CA (US);
Wenli MA, Mountain View, CA (US);
Yukiharu Matsumoto, Gifu, JP;
Kunihisa Baba, Yokkaichi, JP;
Hideaki Inagaki, Inabe, JP;
Katsumasa Tanaka, Inabe, JP;
Yoshiro Ishiwata, Aichi-gun, JP;
Shoji Yokochi, Inabe-gun, JP;
Masayuki Okamoto, Tokyo-to, JP;
Takashi Nakamura, Kuwana, JP;
Atsushi Miyachi, Kuwana, JP;
Mitsuaki Takeuchi, Inabe, JP;
Kouji Matsushima, Matsudo, JP;
Edgardo Laborde, Foster City, CA (US);
Louise Robinson, San Carlos, CA (US);
Fanying Meng, San Francisco, CA (US);
Brian T. Peterson, Mountain View, CA (US);
Hugo O. Villar, La Jolla, CA (US);
Steven E. Anuskiewicz, San Bruno, CA (US);
Wenli Ma, Mountain View, CA (US);
Yukiharu Matsumoto, Gifu, JP;
Kunihisa Baba, Yokkaichi, JP;
Hideaki Inagaki, Inabe, JP;
Katsumasa Tanaka, Inabe, JP;
Yoshiro Ishiwata, Aichi-gun, JP;
Shoji Yokochi, Inabe-gun, JP;
Masayuki Okamoto, Tokyo-to, JP;
Takashi Nakamura, Kuwana, JP;
Atsushi Miyachi, Kuwana, JP;
Mitsuaki Takeuchi, Inabe, JP;
Kouji Matsushima, Matsudo, JP;
Telik, Inc., Palo Alto, CA (US);
Sanwa Kagaku Kenkyusho Co., Ltd., Nagoya, JP;
Abstract
Compounds of formula A and formula B:and their pharmaceutically acceptable salts, compositions comprising them, methods for their use, and their use in the preparation of medicaments. The compounds are antagonists of MCP-1 function, and are useful in the prevention and treatment of chronic or acute inflammatory or autoimmune diseases, such as multiple sclerosis, and in the prevention and treatment of allergic hypersensitivity disorders.